Europe POCT Market – Industry Trends and Forecast to 2026

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email
US : +1-888-387-2818
UK : +44 208 089 1725

Europe POCT Market – Industry Trends and Forecast to 2026

Europe
Publish Reports
Europe POCT Market
  • No of pages :
    215
  • No of Figures:
    24
  • No of Tables:
    132
  • Report Type:
    Publish

Europe POCT Market By Device Type (Handheld and Bench Top), Product (cardio-metabolic monitoring, glucose monitoring, fertility and pregnancy, coagulation monitoring, infectious disease, hematology, tumor marker, urinalysis testing, cholesterol test, drug abuse testing, fecal occult testing and others), Diseases (cardiology, diabetes, gynecology, respiratory diseases, liver diseases and others), Prescription Mode (over the counter and prescription based), End User (laboratories, diagnostic centers, hospitals, home care settings, clinics and  ambulance service) and Country (Germany, U.K.,  France, Spain, Italy, Switzerland, Denmark, Belgium, Norway, Sweden, Netherlands, Russia, Turkey and Rest of Europe) – Industry Trends and Forecast to 2026

Point-of-care testing (POCT) is defined as the testing of samples taken from a patient and performed at or near the bedside, with the result leading to possible changes in the care of that individual. It is a diagnostic test which is conducted close to the site where clinical care needs to be delivered. POCT is often accomplished through the use of light, portable, and handheld instruments (blood glucose meter, INR meter). POCT is an alternative to central or core laboratory testing.

These tests are accomplished through the use of transportable, portable, and handheld instruments. Bench analysers are also available for the purpose of testing of pH, electrolyte, blood gas and haemoglobin measurement of the blood samples. Analysers are also available for rapid and accurate analysis of urine.

Europe POCT Market is projected to register a healthy CAGR of 7.6% in the forecast period of 2019 to 2026.

Segmentation: Europe POCT Market

Europe POCT Market is segmented into 6 notable segments that is device type, product, diseases, prescription mode and end user.

  • On the basis of device type, the market is segmented into Handheld and Bench Top devices.
    • In March 2019, F. Hoffmann-La Roche Ltd announced the approval from FDA for the combination of Tecentriq with chromatography for the initial treatment of the adults who suffer from small cell lung cancer.
  • On the basis of product, the market is segmented into cardio-metabolic monitoring, glucose monitoring, fertility and pregnancy, coagulation monitoring, infectious disease, hematology, tumor marker, urinalysis testing, cholesterol test, drug abuse testing, fecal occult testing and others. Cardio-Metabolic Monitoring is further sub segmented into cardiac markers, hb1ac testing, blood gas/electrolytes and lipid testing. Fertility and Pregnancy is further sub segmented into pregnancy testing kits and fertility testing kits. Coagulation Monitoring is further sub segmented into ACT/APTT testing and PT/INR testing. Infectious disease is further sub segmented into Influenza/Flu POC, HIV POC, Hepatitis C Virus (HCV) POC, STD testing, tropical diseases testing, respiratory infections testing and other infectious diseases.
    • In January 2019, Siemens Healthineers announced its signing of a technological partnership with the Spanish Hospital. This performance-oriented partnership was done to ensure the availability of medical hardware and software for years to come.
  • On the basis of diseases, the market is segmented into cardiology, diabetes, gynecology, respiratory diseases, liver diseases and others.
    • In January 2018, Siemens Healthineers announced the closing of the acquisition of Fast Track Diagnostics (Luxembourg) which expanded Siemens molecular diagnostics portfolio.
  • On the basis of prescription mode, the market is segmented into over the counter and prescription based.
    • In September 2018, Hologic, Inc. announced the acquisition of Focal Theraputics at an expense of USD 125 Million. This acquisition helped the company for strengthening their Breast Surgery Franchise.
  • On the basis of end user, the market is segmented laboratories, diagnostic centers, hospitals, home care settings, clinics and ambulance service.
    • In May 2017, ACON Laboratories announced the clearance of Mission Microalbumin/Creatinine Urine Reagent Strips this product is a urine qualitative dipstick used as a kidney screening tool.

Competitive Analysis: Europe POCT Market

Some of the major players operating in this market are F. Hoffmann-La Roche Ltd., Siemens, Holigic Inc. Abaxis,  Acon Laboratories, Inc., Randox Laboratories, Ltd., Danaher, Abott, Thermo Fisher Scientific, Inc., Trivitron Healthcare, Cavidi, Clarity Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Becton, Dickinson and Company, Nova Biomedical, Trinity Biotech, Chembio Diagnostic Systems, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Biomérieux SA.

Product Launch:

  • In 2019, Hologic, Inc. announced the launch of their Business Intelligence Tool, Unifi Analytics, which is an essential tool for maximizing efficiency and reducing the downtime in the suite of mammography.
  • In 2017, ACON Laboratories announced the launch of their product Mission PT/INR Monitoring System. This product is considered the future of oral anticoagulation therapy
  • In 2019, Thermo Fisher Scientific announced the launch of their new product line which was series of compact refrigerator for the patient care facility. This series go by the name Thermo Scientific TSG Series.
  • In July, Thermo Fisher Scientific announced the launch of their new product Phadia 200 Advances In-vitro Diagnostics which us was used for the detection and monitoring of allergy and autoimmunity conditions.

Research Methodology: Europe POCT Market

Primary Respondents: Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.

Choose Licence Type

Enterprise, Single User

TABLE OF CONTENTS EUROPE POCT MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE POCT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR VENDOR SHARE ANALYSIS
2.9 MULTIVARIATE MODELING
2.10 PRODUCTS LIFELINE CURVE
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 TECHNOLOGICAL ADVANCEMENTS IN POCT DEVICES
3.1.2 INCREASED USAGE OF POCT DEVICES IN HOMECARE SETTINGS
3.1.3 RISING INCIDENCES OF CHRONIC DISEASES
3.1.4 GROWING DEMAND FOR WEARABLE DEVICES

3.2 RESTRAINTS

3.2.1 PRODUCT RECALLS: HAMPERING USER CONFIDENCE
3.2.2 RISING COST OF POCT DEVICES
3.2.3 UNFAVOURABLE REIMBURSEMENT SCENARIO

3.3 OPPORTUNITIES

3.3.1 POC TESTS WITH MULTIPLEXED CAPABILITIES
3.3.2 EMERGING MICROFLUIDIC LAB-ON–A–CHIP TECHNOLOGY

3.4 CHALLENGES

3.4.1 RELUCTANCE TOWARDS CHANGE IN EXISTING DIAGNOSTIC PRACTICES
3.4.2 LACK OF ACCURACY AND EFFICIENCY
3.4.3 DATA MANAGEMENT AND LACK OF CONNECTIVITY
3.4.4 TESTING PERFORMED BY NON-LABORATORY PERSONNEL AND LACK OF AWARENESS AMONG THE USERS

4 REGULATORY SCENARIO

4.1 OVERVIEW
4.2 REGULATORY PROCEDURE:
4.3 CE MARKING

5 REIMBURSEMENT SCENARIO

5.1 OVERVIEW

6 EXECUTIVE SUMMARY

7 PREMIUM INSIGHTS

8 KEY PRIMARY INSIGHTS

9 EUROPE POCT MARKET, BY DEVICE TYPE

9.1 OVERVIEW
9.2 HANDHELD
9.3 BENCH TOP

10 EUROPE POCT MARKET, BY PRODUCT

10.1 OVERVIEW
10.2 CARDIO-METABOLIC MONITORING

10.2.1 CARDIAC MARKERS
10.2.2 HB1AC TESTING
10.2.3 BLOOD GAS/ELECTROLYTES
10.2.4 LIPID TESTING

10.3 GLUCOSE MONITORING
10.4 FERTILITY AND PREGNANCY

10.4.1 PREGNANCY TESTING KITS
10.4.2 FERTILITY TESTING KITS

10.5 COAGULATION MONITORING

10.5.1 ACT/APTT TESTING
10.5.2 PT/INR TESTING

10.6 INFECTIOUS DISEASE

10.6.1 INFLUENZA/FLU POC
10.6.2 HIV POC
10.6.3 HEPATITIS C VIRUS (HCV) POC
10.6.4 STD TESTING
10.6.5 TROPICAL DISEASES TESTING
10.6.6 RESPIRATORY INFECTIONS TESTING
10.6.7 OTHER INFECTIOUS DISEASES

10.7 HEMATOLOGY
10.8 TUMOR MARKER
10.9 URINALYSIS TESTING
10.10 CHOLESTEROL TEST
10.11 DRUG ABUSE TESTING
10.12 FECAL OCCULT TESTING
10.13 OTHERS

11 EUROPE POCT MARKET, BY DISEASES

11.1 OVERVIEW
11.2 CARDIOLOGY
11.3 DIABETES
11.4 GYNAECOLOGY
11.5 RESPIRATORY DISEASES
11.6 LIVER DISEASES
11.7 OTHERS

12 EUROPE POCT MARKET, BY PRESCRIPTION MODE

12.1 OVERVIEW
12.2 PRESCRIPTION BASED
12.3 OVER THE COUNTER

13 EUROPE POCT MARKET, BY END-USER

13.1 OVERVIEW
13.2 LABORATORIES
13.3 DIAGNOSTIC CENTERS
13.4 HOSPITALS
13.5 HOME CARE SETTINGS
13.6 CLINICS
13.7 AMBULANCE SERVICE

14 EUROPE POCT MARKET, BY COUNTRY

14.1 EUROPE

14.1.1 GERMANY
14.1.2 U.K.
14.1.3 FRANCE
14.1.4 SPAIN
14.1.5 ITALY
14.1.6 SWITZERLAND
14.1.7 DENMARK
14.1.8 BELGIUM
14.1.9 NORWAY
14.1.10 SWEDEN
14.1.11 NETHERLANDS
14.1.12 RUSSIA
14.1.13 TURKEY
14.1.14 REST OF EUROPE

15 EUROPE POCT MARKET, COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: EUROPE

16 COMPANY PROFILES

16.1 ABBOTT

16.1.1 COMPANY SNAPSHOT
16.1.2 SWOT ANALYSIS
16.1.3 REVENUE ANALYSIS
16.1.4 GEOGRAPHICAL PRESENCE
16.1.5 PRODUCT PORTFOLIO
16.1.6 RECENT DEVELOPMENTS
16.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

16.2 F. HOFFMANN-LA ROCHE LTD.

16.2.1 COMPANY SNAPSHOT
16.2.2 SWOT ANALYSIS
16.2.3 REVENUE ANALYSIS
16.2.4 GEOGRAPHICAL PRESENCE
16.2.5 PRODUCT PORTFOLIO
16.2.6 RECENT DEVELOPMENTS
16.2.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

16.3 BIOMÉRIEUX SA

16.3.1 COMPANY SNAPSHOT
16.3.2 SWOT ANALYSIS
16.3.3 REVENUE ANALYSIS
16.3.4 GEOGRAPHICAL PRESENCE
16.3.5 PRODUCT PORTFOLIO
16.3.6 RECENT DEVELOPMENTS
16.3.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

16.4 SIEMENS

16.4.1 COMPANY SNAPSHOT
16.4.2 SWOT ANALYSIS
16.4.3 REVENUE ANALYSIS
16.4.4 GEOGRAPHICAL PRESENCE
16.4.5 PRODUCT PORTFOLIO
16.4.6 RECENT DEVELOPMENTS
16.4.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

16.5 DANAHER

16.5.1 COMPANY SNAPSHOT
16.5.2 SWOT ANALYSIS
16.5.3 REVENUE ANALYSIS
16.5.4 GEOGRAPHICAL PRESENCE
16.5.5 PRODUCT PORTFOLIO
16.5.6 RECENT DEVELOPMENTS
16.5.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

16.6 ABAXIS

16.6.1 COMPANY SNAPSHOT
16.6.2 GEOGRAPHICAL PRESENCE
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS

16.7 ACON LABORATORIES, INC.

16.7.1 COMPANY SNAPSHOT
16.7.2 GEOGRAPHICAL PRESENCE
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS

16.8 BECTON, DICKINSON AND COMPANY

16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 GEOGRAPHICAL PRESENCE
16.8.4 PRODUCT PORTFOLIO
16.8.5 RECENT DEVELOPMENTS

16.9 BIO-RAD LABORATORIES, INC.

16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 GEOGRAPHICAL PRESENCE
16.9.4 PRODUCT PORTFOLIO
16.9.5 RECENT DEVELOPMENT

16.10 CAVIDI

16.10.1 COMPANY SNAPSHOT
16.10.2 GEOGRAPHICAL PRESENCE
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS

16.11 CHEMBIO DIAGNOSTIC SYSTEMS, INC.

16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 GEOGRAPHICAL PRESENCE
16.11.4 PRODUCT PORTFOLIO
16.11.5 RECENT DEVELOPMENTS

16.12 CLARITY DIAGNOSTICS

16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT

16.13 HOLIGIC INC

16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 GEOGRAPHICAL PRESENCE
16.13.4 PRODUCT PORTFOLIO
16.13.5 RECENT DEVELOPMENTS

16.14 NOVA BIOMEDICAL

16.14.1 COMPANY SNAPSHOT
16.14.2 GEOGRAPHICAL PRESENCE
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENTS

16.15 RANDOX LABORATORIES, LTD.

16.15.1 COMPANY SNAPSHOT
16.15.2 GEOGRAPHICAL PRESENCE
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS

16.16 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

16.16.1 COMPANY SNAPSHOT
16.16.2 GEOGRAPHICAL PRESENCE
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS

16.17 SYSMEX CORPORATION

16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 GEOGRAPHICAL PRESENCE
16.17.4 PRODUCT PORTFOLIO
16.17.5 RECENT DEVELOPMENTS

16.18 THERMO FISHER SCIENTIFIC, INC.

16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 GEOGRAPHICAL PRESENCE
16.18.4 PRODUCT PORTFOLIO
16.18.5 RECENT DEVELOPMENTS

16.19 TRINITY BIOTECH

16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 GEOGRAPHICAL PRESENCE
16.19.4 PRODUCT PORTFOLIO
16.19.5 RECENT DEVELOPMENTS

16.20 TRIVITRON HEALTHCARE

16.20.1 COMPANY SNAPSHOT
16.20.2 GEOGRAPHICAL PRESENCE
16.20.3 PRODUCT PORTFOLIO
16.20.4 RECENT DEVELOPMENTS

17 CONCLUSION

18 QUESTIONNAIRE

19 RELATED REPORTS

LIST OF TABLES EUROPE POCT MARKET

TABLE 1 SUMMARY OF REIMBURSEMENT IN EUROPEAN COUNTRIES FOR CRP POCT

TABLE 2 LIST OF DIFFERENT TYPES OF APPROVAL FOR DIFFERENT COUNTRIES

TABLE 3 EUROPE POCT MARKET, BY DEVICE TYPE , 2017-2026 (USD MILLION)

TABLE 4 EUROPE POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 5 EUROPE CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 6 EUROPE FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 7 EUROPE COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 8 CLIA-WAIVED TESTS FOR INFECTIOUS DISEASES

TABLE 9 EUROPE INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 10 COMMERCIALLY AVAILABLE POC DEVICES FOR CANCER DETECTION

TABLE 11 EUROPE POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 12 EUROPE POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 13 EUROPE POCT MARKET, BY END-USER , 2017-2026 (USD MILLION)

TABLE 14 EUROPE POCT MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 15 GERMANY POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 16 GERMANY POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 17 GERMANY CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 18 GERMANY FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 19 GERMANY COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 20 GERMANY INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 21 GERMANY POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 22 GERMANY POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 23 GERMANY POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 24 U.K. POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 25 U.K. POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 26 U.K. CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 27 U.K. FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 28 U.K. COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 29 U.K. INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 30 U.K. POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 31 U.K. POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 32 U.K. POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 33 FRANCE POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 34 FRANCE POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 35 FRANCE CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 36 FRANCE FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 37 FRANCE COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 38 FRANCE INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 39 FRANCE POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 40 FRANCE POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 41 FRANCE POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 42 SPAIN POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 43 SPAIN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 44 SPAIN CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 45 SPAIN FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 46 SPAIN COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 47 SPAIN INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 48 SPAIN POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 49 SPAIN POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 50 SPAIN POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 51 ITALY POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 52 ITALY POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 53 ITALY CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 54 ITALY FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 55 ITALY COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 56 ITALY INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 57 ITALY POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 58 ITALY POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 59 ITALY POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 60 SWITZERLAND POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 61 SWITZERLAND POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 62 SWITZERLAND CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 63 SWITZERLAND FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 64 SWITZERLAND COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 65 SWITZERLAND INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 66 SWITZERLAND POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 67 SWITZERLAND POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 68 SWITZERLAND POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 69 DENMARK POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 70 DENMARK POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 71 DENMARK CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 72 DENMARK FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 73 DENMARK COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 74 DENMARK INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 75 DENMARK POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 76 DENMARK POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 77 DENMARK POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 78 BELGIUM POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 79 BELGIUM POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 80 BELGIUM CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 81 BELGIUM FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 82 BELGIUM COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 83 BELGIUM INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 84 BELGIUM POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 85 BELGIUM POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 86 BELGIUM POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 87 NORWAY POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 88 NORWAY POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 89 NORWAY CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 90 NORWAY FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 91 NORWAY COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 92 NORWAY INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 93 NORWAY POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 94 NORWAY POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 95 NORWAY POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 96 SWEDEN POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 97 SWEDEN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 98 SWEDEN CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 99 SWEDEN FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 100 SWEDEN COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 101 SWEDEN INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 102 SWEDEN POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 103 SWEDEN POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 104 SWEDEN POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 105 NETHERLANDS POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 106 NETHERLANDS POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 107 NETHERLANDS CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 108 NETHERLANDS FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 109 NETHERLANDS COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 110 NETHERLANDS INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 111 NETHERLANDS POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 112 NETHERLANDS POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 113 NETHERLANDS POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 114 RUSSIA POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 115 RUSSIA POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 116 RUSSIA CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 117 RUSSIA FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 118 RUSSIA COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 119 RUSSIA INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 120 RUSSIA POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 121 RUSSIA POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 122 RUSSIA POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 123 TURKEY POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

TABLE 124 TURKEY POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 125 TURKEY CARDIO-METABOLIC MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 126 TURKEY FERTILITY AND PREGNANCY IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 127 TURKEY COAGULATION MONITORING IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 128 TURKEY INFECTIOUS DISEASE IN POCT MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 129 TURKEY POCT MARKET, BY DISEASES, 2017-2026 (USD MILLION)

TABLE 130 TURKEY POCT MARKET, BY PRESCRIPTION MODE, 2017-2026 (USD MILLION)

TABLE 131 TURKEY POCT MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 132 REST OF EUROPE POCT MARKET, BY DEVICE TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES EUROPE POCT MARKET

FIGURE 1 EUROPE POCT MARKET: SEGMENTATION

FIGURE 2 EUROPE POCT MARKET : GEOGRAPHICAL SCOPE

FIGURE 3 EUROPE POCT MARKET: DATA VALIDATION MARKET

FIGURE 4 EUROPE POCT MARKET: DROC ANALYSIS

FIGURE 5 EUROPE POCT MARKET: REGION VS COUNTRY ANALYSIS

FIGURE 6 EUROPE POCT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 7 EUROPE POCT MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 EUROPE POCT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE POCT MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE POCT MARKET

FIGURE 11 EUROPE POCT MARKET SEGMENTATION

FIGURE 12 GROWING DEMAND OF WEARABLE DEVICES IS EXPECTED TO DRIVE THE MARKET FOR EUROPE POCT MARKET IN THE FORECAST PERIOD OF 2019 TO 2026

FIGURE 13 CARDIO-METABOLIC MONITORING IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE POCT MARKET IN 2019 & 2026

FIGURE 14 EUROPE POCT MARKET: BY DEVICE TYPE, 2018

FIGURE 15 EUROPE POCT MARKET: BY PRODUCT, 2018

FIGURE 16 EUROPE POCT MARKET: BY DISEASES, 2018

FIGURE 17 EUROPR POCT MARKET: BY PRESCRIPTION MODE, 2018

FIGURE 18 EUROPE POCT MARKET: BY END-USER, 2018

FIGURE 19 EUROPE POCT MARKET: SNAPSHOT (2018)

FIGURE 20 EUROPE POCT MARKET: BY COUNTRY (2018)

FIGURE 21 EUROPE POCT MARKET: BY COUNTRY (2019 & 2026)

FIGURE 22 EUROPE POCT MARKET: BY COUNTRY (2018 & 2026)

FIGURE 23 EUROPE POCT MARKET: BY DEVICE TYPE (2019 – 2026)

FIGURE 24 EUROPE POCT MARKET: COMPANY SHARE 2018 (%)

Please fill in the below form and our sales representatives will get back to you Shortly

Please fill in the below form and our sales representatives will get back to you Shortly

`